CCN5 and neoplasm: Since EGCG treatment resulted in proliferating cell nuclear antigen (PCNA) downregulation and activation of CCN5 in tumor tissues, tumor growth inhibition could be mediated via suppressing PCNA, a protein that actively participates in cell cycle regulation and apoptosis,51 and CCN5 activation.